Dyspnea management in lung cancer: Applying the evidence from chronic obstructive pulmonary disease

Oncology Nursing Forum

Volumn 32, Issue 4, 2005, Pages 785-797

  Jantarakupt, Peeranuch ^a   Porock, Davina ^b  

^a Mc Cormick Hospital   (Thailand)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LOCAL ANESTHETIC AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; HUMAN; LUNG TUMOR; NURSING; OXYGEN THERAPY; REVIEW; RISK FACTOR;

ADRENAL CORTEX HORMONES; ANESTHETICS, LOCAL; ANTI-ANXIETY AGENTS; BRONCHODILATOR AGENTS; DYSPNEA; HUMANS; LUNG NEOPLASMS; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 33645871866     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/05.ONF.785-797     Document Type: Article

References (79)

1. Ahmedzai, S. ( 1998). Palliation of respiratory symptoms. In D. Doyle, G.W. Hanks, & N. MacDonald (Eds.), Oxford textbook of palliative medicine (2nd ed., pp. 583-561). New York: Oxford Medical.
2. Akrabawi, S.S., Mobarhan, S., Stoltz, R.R., & Ferguson, P.W. (1996). Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmonary disease patients. Nutrition, 12, 260-265.
3. Beachey, W. (1998). Respiratory care anatomy and physiology: Foundations for clinical practice. St. Louis, MO: Mosby.
4. Beauford, W., Saylor, T.T., Stansbury, D.W., Avalos, K., & Light, R.W. (1993). Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest, 104, 175-178.
5. Belville-Robertson, T. (1999). Coping strategy and social support differences among COPD patients: Effects on psychological well-being, functional status, and health care utilization. Unpublished doctoral dissertation, Western Michigan University.
6. Birks, C. (1997). Pathophysiology and management of dyspnea in palliative care and the evolving role of the nurse. International Journal of Palliative Nursing, 3, 264-274.
7. Boyd, K.J., & Kelly, M. (1997). Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliative Medicine, 11, 277-281.
8. Breslin, E.H. (1992). The pattern of respiratory muscle recruitment during pursed-lip breathing. Chest, 101, 75-78.
9. Bruera, E., de Stoutz, N., Velasco-Leiva, A., Schoeller, T., & Hanson, J. (1993). Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet, 342, 13-14.
10. Bruera, E., MacEachern, T., Ripamonti, C., & Hanson, J. (1993). Subcutaneous morphine for dyspnea in cancer patients. Annals of Internal Medicine, 119, 906-907.
11. Bruera, E., Macmillan, K.. Pither, J., & MacDonald, R.N. (1990). Effects of morphine on the dyspnea of terminal cancer patients. Journal of Pain and Symptom Management, 5, 341-344.
12. Bruera, E., Schmilz, B., Pither, J., Neumann, C.M., & Hanson, J. (2000). The frequency and correlates of dyspnea in patients with advanced cancer. Journal of Pain and Svwptom Management, 19, 357-362.
13. Carrieri-Kohlman, V., & Stulbarg, M.S. (2001). Dyspnea: Assessment and management. In J.E. Hodgkin, B.R. Celli, & G.L. Connors (Eds.). Pulmonary rehabilitation: Guidelines to success (3rd ed., pp. 57-89). Philadelphia: Lippincott Williams and Wilkins.
14. Chapman, K.M., & Winter, L. (1996). COPD: Using nutrition to prevent respiratory function decline. Geriatrics, 5/(12), 37-42.
15. Cleeland, C.S. (2000). Cancer-related symptoms. Seminars in Radiation Oncology, 10, 175-190.
16. Cohen, M.H., Anderson, A.J., Krasnow, S.H., Spagnolo, S.V., Citron, M.L., Payne, M., et al. (1991). Continuous intravenous infusion of morphine for severe dyspnea. Southern Medical Journal, 84, 229-234.
17. Coppola, S., & Wood, W. (2001). Occupational therapy to promote function and health-related quality of life. In J.E. Hodgkin, B.R. Celli, & G.L. Connors (Eds.), Pulmonary rehabilitation: Guidelines to success (3rd ed., pp. 103-112). Philadelphia: Lippincott Williams and Wilkins.
18. Couser, J.I. (2001). Pharmacologic therapy. In J.E. Hodgkin, B.R. Celli, & G.L. Connors (Eds.), Pulmonary rehabilitation: Guidelines to success (3rd ed., pp. 103-111). Philadelphia: Lippincott Williams and Wilkins.
19. Covelli, H.D., Black, J.W., Olsen, M.W., & Beekman, J.F. (1981). Respiratory failure precipitated by high carbohydrate loads. Annals of Internal Medicine, 95, 579-581.
20. Cowcher, K., & Hanks, G.W. (1990). Long-term management of respiratory symptoms in advanced cancer. Journal of Pain and Symptom Management, 5, 320-330.
21. Des Jardins, T.R., & Burton, G.G. (2002). Clinical manifestations and assessment of respiratory disease (4th ed.). St. Louis, MO: Mosby.
22. Dudgeon, D.J., & Rosenthal, S. (1996). Management of dyspnea and cough in patients with cancer. Hemalology/Oncology Clinics of North America, 10, 157-171.
23. Dunlop, R. (1998). Cancer: Palliative care. London: Springer-Verlag.
24. Escalante, C.P., Martin, C.G., Elting, L.S., Cantor, S.B., Harle, T.S., Price, K.J., et al. (1996). Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer, 78, 1314-1319.
25. Farncombe, M., & Chater, S. (1993). Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac disease. Journal of Pain and Symptom Management, 8, 221-225.
26. Farncombe, M., Chater, S., & Gillin, A. (1994). The use of nebulized opioids for breathlessness: A chart review. Palliative Medicine, 8, 306-312.
27. Ferreira, I.M., Brooks, D., Lacasse, Y., & Goldstein, R.S. (2000). Nutritional support for individuals with COPD: A meta-analysis. Chest, 117, 672-678.
28. Fink, J.B. (1999). Respiratory anatomy and physiology. In J.B. Fink & G.E. Hunt (Eds.), Clinical practice in respiratory care (pp. 45-77). Philadelphia: Lippincott Williams and Wilkins.
29. Florez, J., Pazos, A., Hurle, M.A., & Mediavilla, A. (1983). Focusing on the respiratory actions of opioids. Trends of Pharmacological Science, 4, 470-72.
30. Foote, M., Sexton, D.L., & Pawlik, L. (1986). Dyspnea: A distressing sensation in lung cancer. Oncology Nursing Forum, 13(5), 25-31.
31. Ganzoni, A., Heilig, P., Schonenberger, K., Hugli, O., Fitting, J.W., & Brandli, O. (1994). High-caloric nutrition in chronic obstructive lung disease. Schweizerische Rundschau fur Medizin Praxis, 83, 13-16.
32. Garvey, C. (1998). COPD and exercise. Lippincott's Primary Care Practice, 2, 589-598.
33. Gift, A.G. (1990). Dyspnea. Nursing Clinics of North America, 25, 955-965.
34. Gift, A.C., Moore, T., & Soeken, K. (1992). Relaxation to reduce dyspnea and anxiety in COPD patients. Nursing Research, 41, 242-246.
35. Goldstein, S.A., Askanazi, J., Elwyn, D.H., Thomashow, B., Milic-Emili, J., Kvetan, V., et al. (1989). Submaximal exercise in emphysema and malnutrition at two levels of carbohydrate and fat intake. Journal of Applied Physiology, 67, 1048-1055.
36. Grant, M., & Kravits, K. (2000). Symptoms and their impact on nutrition. Seminars in Oncology Nursing, 16, 113-121.
37. Grey, A. (1995). The nursing management of dyspnoea in palliative care. Nursing Times, 91, 32-35.
38. Heyse-Moore, L.H., Ross, V., & Mullee, M.A. (1991). How much of a problem is dyspnoea in advanced cancer? Palliative Medicine, 5, 20-26.
39. Kornfeld, H.S. ( 1995). Co-meditation: Guiding patients through the relaxation process. RN, 58(1 1), 57-59.
40. Koyama, H., Nishimura, K., Mio, T., & Izumi, T. (1992). Response to oral corticosteroid in patients with chronic obstructive pulmonary disease. Internal Medicine, 31, 1179-1184.
41. Lake, F.R., Henderson, K., Briffa, T., Openshaw, J., & Musk, A.W. (1990). Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction. Chest, 97, 1077-1082.
42. Landbo, C., Prescott, E., Lange, P., Vestbo, J., & Almdal, T.P. (1999). Prognostic value of nutritional status in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 160, 1856-1861.
43. Leff, A.R., & Schumacker, P.T. (1993). Respiratory physiology: Basic and applications. Philadelphia: Saunders.
44. LeGrand, S.B., & Walsh, D. (1999). Palliative management of dyspnea in advanced cancer. Current Opinion in Oncology, 11, 250-254.
45. Light, R.W., Muro, J.R., Sato, R.I., Stansbury, D.W., Fischer, C.E., & Brown, S.E. (1989). Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. American Review of Respiratory Disease, 139, 126-133.
46. Macklon, A.F., Barton, M., James, O., & Rawlins, M.D. (1980). The effect of age on the pharmacokinetics of diazepam. Clinical Science, 59, 479-483.
47. Murciano, D., Auclair, M.H., Pariente, R., & Aubier, M. (1989). A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. New England Journal of Medicine, 320, 1521-1525.
48. O'Donnell, D.E., Webb, K.A., & McGuire, M.A. (1993). Older patients with COPD: Benefits of exercise training. Geriatrics, 48, 59-62, 65-66.
49. O'Neill, S., & McCarthy, D.S. (1983). Postural relief of dyspnoea in severe chronic airflow limitation: Relationship to respiratory muscle strength. Thorax, 38, 595-600.
50. Phillips, Y.Y., Hnatiuk, D.W., & Torrington, K. (1997). Chronic obstructive pulmonary disease. In G.G. Burton, J.E. Hodgkin, & J.J. Ward (Eds.), Respiratory care: A guide to clinical practice (4th ed., pp. 1019-1041). Philadelphia: Lippincott Williams and Wilkins.
51. Quinn, S. (1999). Lung cancer: The role of the nurse in treatment and prevention. Nursing Standard, 13(41), 49-54.
52. Rabinowitz, B., & Florian, V. (1992). Chronic obstructive pulmonary disease - Psychosocial issues and treatment goals. Social Work in Health Care, 16, 69-86.
53. Ries, A.L., Bullock, P.J., Larsen, C.A., Limberg, T.M., Myers, R., Pfister, T., et al. (2001). Shortness of breath: A guide to better living and breathing (6th ed.). St. Louis, MO: Mosby.
54. Ries, A.L., Ellis, B., & Hawkins, R.W. (1988). Upper extremity exercise training in chronic obstructive pulmonary disease. Chest, 93, 688-692.
55. Ries, A.L., Kaplan, R.M., Limberg, T.M., & Prewitt, L.M. (1995). Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Annals of Internal Medicine, 122, 823-832.
56. Rifas, E.M. (1980). How you and your patients can manage dyspnea. Nursing, 70(6), 34-41.
57. Roberts, D.K., Thorne, S.E., & Pearson, C. (1993). The experience of dyspnea in late-stage cancer: Patients' and nurses' perspectives. Cancer Nursing, 76, 310-320.
58. Rousseau, P. (1996). Nonpain symptom management in terminal care. Clinics in Geriatric Medicine, 12, 313-327.
59. Ryan, C.F., Road, J.D., Buckley, P.A., Ross, C., & Whittaker, J.S. (1993). Energy balance in stable malnourished patients with chronic obstructive pulmonary disease. Chest, 103, 1038-1044.
60. Schols, A.M. & Wouters, E.F. (2000). Nutritional assessment and support. In J.E. Hodgkin, B.R. Celli, & G.L. Connors (Eds.), Pulmonary rehabilitanon: Guidelines to success (3rd ed., pp. 247-259). Philadelphia: Lippincott Williams and Wilkins.
61. Schonhofer, B., Suchi, S., Haidl, P., & Kohler, D. (2001). "Epidemiology" of the value of orally administered morphine as therapy of severe pulmonary emphysema of the pink-puffer type. Medizinische Klinik, 96, 325-330.
62. Sestini, P., Renzoni, E., Robinson, S., Poole, P., & Ram, F.S. (2000). Shortacting beta 2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 3, CD001495. Retrieved May 17, 2001, from Cochrane Database of Systematic Reviews.
63. Sexton, D.L. (1990). Nursing care of the respiratory patient. Norwalk, CT: Appleton and Lange.
64. Sharp, J.T., Drutz, W.S., Moisan, T., Foster, J., & Machnach, W. (1980). Postural relief of dyspnea in severe chronic pulmonary disease. American Review of Respiratory Disease, 122, 201-211.
65. Sheehan, D.C., & Forman, W.B. (1997). Symptomatic management of the older person with cancer. Clinical Geriatric Medicine, 13, 203-219.
66. Sodha, M., & Frampton, D. (1995). Dyspnea and cough. Pharmaceutical Journal, 254, 653-655.
67. Song, Y., Kang, X.M., & Xia, X.R. (1993). Clinical observation on short-term nutritional support in the treatment of advanced chronic obstructive pulmonary disease. Chinese Journal of Internal Medicine, 32, 819-822.
68. Swinburn, C.R., Mould, H., Stone, T.N., Corns, P.A., & Gibson, G.J. (1991). Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. American Review of Respiratory Disease, 143(5, Pt. 1), 913-915.
69. Tanaka, K., Shima, Y., Kakinuma, R., Kubota, K., One, Y., Hojo, F., et al. (1999). Effect of nebulized morphine in cancer patients with dyspnea: A pilot study. Japanese Journal of Clinical Oncology, 29, 600-603.
70. Turner, J.A. ( 1992). Nursing care of the terminal lung cancer patient. Nursing Clinics of North America, 27, 691-702.
71. Vainio, A., & Auvinen, A. (1996). Prevalence of symptoms among patients with advanced cancer: An international collaborative study. Journal of Pain and Symptom Management, 12, 3-10.
72. Vermeeren, M.A., Wouters, E.F., Nelissen, L.H., van Lier, A., Hofman, Z., & Schols, A.M. (2001). Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. American Journal of Clinical Nutrition, 73, 295-301.
73. Vitacca, M., Clini, E., Bianchi, L., & Ambrosino, N. (1998). Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency. European Respiratory Journal, 11, 408-415.
74. Wickham, R.S. (1998). Managing dyspnea in cancer patients. Development in Supportive Cancer Care, 2(2), 33-40.
75. Wilson, D.O., Rogers, R.M., Sanders, M.H., Pennock, B.E., & Reilly, J.J. ( 1986). Nutritional intervention in malnourished patients with emphysema. American Review of Respiratory Disease, 134, 672-677.
76. Wood, J.A., Wilson, R.S., & Bray, C. (1986). Changes in salbutamol concentration in the reservoir solution of a jet nebulizer. British Journal of Diseases of the Chest, 80, 164-169.
77. Woodcock, A.A., Gross, E.R., & Geddes, D.M. (1981). Drug treatment of breathlessness: Contrasting effects of diazepam and promethazine in pink puffers. British Medical Journal Clinical Research, 283, 343-346.
78. Young, I.H., Daviskas, E., & Keena, V.A. (1989). Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. Thorax, 44, 387-390.
79. Zeppetella, G. (1997). Nebulized morphine in the palliation of dyspnoea. Palliative Medicine, 11, 267-275.